Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.

Details

Language :

English

ISSN :

03618609

Volume :

89

Issue :

7

Database :

Complementary Index

Journal :

American Journal of Hematology

Publication Type :

Academic Journal

Accession number :

96701057

Full Text :

https://doi.org/10.1002/ajh.23728